Culmerciclib in HR+/HER2+ Advanced Breast Cancer
NCT07732491
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Metastastic Breast Cancer
HER2+ Advanced Breast Cancer
Interventions
DRUG:
Culmerciclib
Sponsor
Sun Yat-sen University